Terms: = Breast cancer AND TBX3, TBX3-ISO, ENSG00000135111, 6926, O15119, XHL, UMS AND Treatment
10 results:
1. Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing.
Takeshita T; Iwamoto T; Niikura N; Watanabe K; Kikawa Y; Kobayashi K; Iwakuma N; Okamura T; Tada H; Ozaki S; Okuno T; Toh U; Yamamoto Y; Tsuneizumi M; Ishiguro H; Masuda N; Saji S
ESMO Open; 2024 Apr; 9(4):102385. PubMed ID: 38387111
[TBL] [Abstract] [Full Text] [Related]
2. An integrated computational approach to screening of alkaloids inhibitors of tbx3 in breast cancer cell lines.
Paul A; Limon MBH; Hossain MM; Raza MT
J Biomol Struct Dyn; 2023 Apr; 41(7):3025-3041. PubMed ID: 35253621
[TBL] [Abstract] [Full Text] [Related]
3. Novel Case of Isolated Peritoneal Carcinomatosis from Metastatic Prostate cancer Carrying a Pathogenic BRCA Mutation Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
King MC; Sardi A; Velez-Mejia C; Sittig M; Ledakis P
Urology; 2021 Sep; 155():210-213. PubMed ID: 34048828
[TBL] [Abstract] [Full Text] [Related]
4. TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of tbx3 in TGF-β1/Smad signaling.
Lee YJ; Park JH; Oh SM
Biochem Biophys Res Commun; 2020 Jan; 522(1):270-277. PubMed ID: 31757421
[TBL] [Abstract] [Full Text] [Related]
5. The Genomic Landscape of Endocrine-Resistant Advanced breast cancers.
Razavi P; Chang MT; Xu G; Bandlamudi C; Ross DS; Vasan N; Cai Y; Bielski CM; Donoghue MTA; Jonsson P; Penson A; Shen R; Pareja F; Kundra R; Middha S; Cheng ML; Zehir A; Kandoth C; Patel R; Huberman K; Smyth LM; Jhaveri K; Modi S; Traina TA; Dang C; Zhang W; Weigelt B; Li BT; Ladanyi M; Hyman DM; Schultz N; Robson ME; Hudis C; Brogi E; Viale A; Norton L; Dickler MN; Berger MF; Iacobuzio-Donahue CA; Chandarlapaty S; Scaltriti M; Reis-Filho JS; Solit DB; Taylor BS; Baselga J
Cancer Cell; 2018 Sep; 34(3):427-438.e6. PubMed ID: 30205045
[TBL] [Abstract] [Full Text] [Related]
6. Knowledge, attitude and perceptions of Muslim cancer patients regarding cancer treatment during Ramadan: Results from a tertiary care hospital Karachi.
Rasheed AA; Rashid YA; Pirzada FT; Haroon F; Jabbar AA; Rahim A
J Pak Med Assoc; 2017 Aug; 67(8):1144-1150. PubMed ID: 28839295
[TBL] [Abstract] [Full Text] [Related]
7. Human breast progenitor cell numbers are regulated by WNT and tbx3.
Arendt LM; St Laurent J; Wronski A; Caballero S; Lyle SR; Naber SP; Kuperwasser C
PLoS One; 2014; 9(10):e111442. PubMed ID: 25350852
[TBL] [Abstract] [Full Text] [Related]
8. Side effects associated with ultrarapid cytochrome P450 2D6 genotype among women with early stage breast cancer treated with tamoxifen.
Rolla R; Vidali M; Meola S; Pollarolo P; Fanello MR; Nicolotti C; Saggia C; Forti L; Agostino FD; Rossi V; Borra G; Stratica F; Alabiso O; Bellomo G
Clin Lab; 2012; 58(11-12):1211-8. PubMed ID: 23289191
[TBL] [Abstract] [Full Text] [Related]
9. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
Zhou SF
Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987
[TBL] [Abstract] [Full Text] [Related]
10. tbx3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases.
Yarosh W; Barrientos T; Esmailpour T; Lin L; Carpenter PM; Osann K; Anton-Culver H; Huang T
Cancer Res; 2008 Feb; 68(3):693-9. PubMed ID: 18245468
[TBL] [Abstract] [Full Text] [Related]
